SEC Form 4 · accession 0001179110-16-028692
INTERMOLECULAR INC · IMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christian Kramer
Officer — CEO
Period of report
Aug 4, 2016
Accepted (ET)
Aug 15, 2016 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311241
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.35 | Aug 4, 2016 | A | 1,000,000 | A | — | Aug 3, 2026 | Common Stock | 1,000,000 | 1,000,000 | D |
Explanation of responses
- F1Twenty-five percent (25%) of the original number of shares subject to the stock option shall vest and become exercisable on the first anniversary of the date of grant and 1/48th of the original number of shares subject to the stock option shall vest and become exercisable on each monthly anniversary of the date of grant thereafter, so that all of the shares subject to the stock option shall be vested and exercisable on the fourth anniversary of the date of grant, subject to the Optionee's continuous service to the Company through each vesting date.